Telomir Pharmaceuticals, Inc.TELO
Price (close)
$1.21
Market cap
$83.2M
P/E
—
Revenue (TTM)
—
Net income
-$5.9M
Dividend yield
—
1-year total return
-13.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What Telomir Pharmaceuticals, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | — | -$854,147 | -$13.1M | -$16.5M | -$10.4M |
More on TELO.
- Telomir Pharmaceuticals, Inc. summary
- Telomir Pharmaceuticals, Inc. financial statements
- Telomir Pharmaceuticals, Inc. key metrics
- Telomir Pharmaceuticals, Inc. health scores and style box
- Telomir Pharmaceuticals, Inc. earnings
- Telomir Pharmaceuticals, Inc. dividends
- Telomir Pharmaceuticals, Inc. valuation
- Telomir Pharmaceuticals, Inc. ownership and insiders
- Telomir Pharmaceuticals, Inc. peers
Figures from Telomir Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.